相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria
Guenter U. Hoeglinger et al.
MOVEMENT DISORDERS (2017)
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia
Lucia A. A. Giannini et al.
NEUROLOGY (2017)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Michael J. Strong et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Ante Mortem Cerebrospinal Fluid Tau Levels Correlate With Postmortem Tau Pathology in Frontotemporal Lobar Degeneration
David J. Irwin et al.
ANNALS OF NEUROLOGY (2017)
APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease
Xiaoyan Sun et al.
ALZHEIMERS & DEMENTIA (2016)
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia
Bryan D. James et al.
BRAIN (2016)
Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD
Cristina Sanfilippo et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Increased CSF neurogranin concentration is specific to Alzheimer disease
Henrietta Wellington et al.
NEUROLOGY (2016)
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
Julia Remnestal et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury
Pashtun Shahim et al.
JAMA NEUROLOGY (2016)
Immununochemical Markers of the Amyloid Cascade in the Hippocampus in motor Neuron Diseases
Ulises Gomez-Pinedo et al.
FRONTIERS IN NEUROLOGY (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
Hlin Kvartsberg et al.
ALZHEIMERS & DEMENTIA (2015)
Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants
Erin E. Franklin et al.
ALZHEIMERS & DEMENTIA (2015)
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease
Erik Portelius et al.
BRAIN (2015)
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
Hlin Kvartsberg et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I. Kester et al.
JAMA NEUROLOGY (2015)
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
David J. Irwin et al.
ACTA NEUROPATHOLOGICA (2015)
sAβPPα Improves Hippocampal NMDA-Dependent Functional Alterations Linked to Healthy Aging
Laura Moreno et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
Jon B. Toledo et al.
ALZHEIMERS & DEMENTIA (2014)
Primary progressive aphasia and the evolving neurology of the language network
M. -Marsel Mesulam et al.
NATURE REVIEWS NEUROLOGY (2014)
Criteria for the diagnosis of corticobasal degeneration
Melissa J. Armstrong et al.
NEUROLOGY (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis
Johannes Brettschneider et al.
ACTA NEUROPATHOLOGICA (2012)
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Neuropathologic substrates of Parkinson disease dementia
David J. Irwin et al.
ANNALS OF NEUROLOGY (2012)
Building an integrated neurodegenerative disease database at an academic health center
Sharon X. Xie et al.
Alzheimers & Dementia (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell et al.
BRAIN RESEARCH (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
A. Drzezga et al.
NEUROLOGY (2009)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
RC3/neurogranin is expressed in pyramidal neurons of motor and somatosensory cortex in normal and denervated monkeys
A Guadaño-Ferraz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling
KP Huang et al.
JOURNAL OF NEUROSCIENCE (2004)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse
JF Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Selective age-related changes in the PKC-sensitive, calmodulin-binding protein, neurogranin, in the mouse brain
N Mons et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)